Free Trial

Sutro Biopharma (STRO) SEC Filings & 10K Form

Sutro Biopharma logo
$1.88 +0.06 (+3.30%)
(As of 12/20/2024 05:31 PM ET)

Recent Sutro Biopharma SEC Filings

DateFilerForm TypeView
12/10/2024
7:00 AM
Sutro Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
6:54 PM
Point72 Asset Management, L.P. (Filed by)
Sutro Biopharma (Subject)
Form SC 13G/A
11/13/2024
3:30 PM
Rubric Capital Management LP (Filed by)
Sutro Biopharma (Subject)
Form SC 13G/A
11/13/2024
3:34 PM
Sutro Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/12/2024
8:34 AM
Adage Capital Management, L.P. (Filed by)
Sutro Biopharma (Subject)
Form SC 13G/A
11/04/2024
1:09 PM
Sutro Biopharma (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
08/13/2024
3:31 PM
Sutro Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/13/2024
3:16 PM
Chung Jane (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
3:38 PM
Jagpal Sukhi (Reporting)
Sutro Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/12/2024
3:40 PM
Jagpal Sukhi (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2024
3:10 PM
Leyman Barbara (Reporting)
Sutro Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/10/2024
3:11 PM
Leyman Barbara (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:29 PM
Petree Daniel H (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:30 PM
Sutro Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2024
3:31 PM
Sutro Biopharma (Issuer)
Wigginton Jon Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:19 PM
Dybbs Michael (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:21 PM
Freund John Gordon (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:22 PM
Hunter Heidi (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:24 PM
Lobacki Joseph M (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2024
3:34 PM
Sutro Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/12/2024
4:59 PM
Srinivasan Venkatesh (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
4:10 PM
Sutro Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2024
3:58 PM
Sutro Biopharma (Filer)
Form 424B5
04/02/2024
5:04 AM
Sutro Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2024
3:30 PM
Sutro Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/22/2024
3:28 PM
NEWELL WILLIAM J (Reporting)
Sutro Biopharma (Issuer)
Form 4/A
03/07/2024
6:12 PM
FITZPATRICK LINDA A (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
3:26 PM
Chung Jane (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
3:28 PM
Gerber Hans-Peter (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
3:31 PM
NEWELL WILLIAM J (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
3:32 PM
Srinivasan Venkatesh (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
3:18 PM
ALBINI EDWARD C (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
3:21 PM
Chung Jane (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
3:40 PM
NEWELL WILLIAM J (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
3:29 PM
ALBINI EDWARD C (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
3:15 PM
Borgman Anne Elizabeth (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
3:33 PM
Sutro Biopharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/13/2024
11:16 AM
Sutro Biopharma (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
Form SC 13G/A
02/12/2024
5:06 AM
Rubric Capital Management LP (Filed by)
Sutro Biopharma (Subject)
Form SC 13G/A
02/09/2024
3:27 PM
Sutro Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2024
6:56 AM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Sutro Biopharma (Subject)
Form SC 13G/A
2025 AI Stock Picks: 2 Hidden Gems Under $10/Share (Ad)

The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.

👉[Click here to get your FREE report delivered instantly!]
01/31/2024
3:23 PM
Sutro Biopharma (Issuer)
Vasquez Nicki (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
3:25 PM
FITZPATRICK LINDA A (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
3:28 PM
ALBINI EDWARD C (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
3:29 PM
NEWELL WILLIAM J (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2024
3:54 PM
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Sutro Biopharma (Subject)
Form SC 13G
01/08/2024
6:31 AM
Sutro Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:STRO) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners